⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
KPTI News
Karyopharm Therapeutics Inc.
Form 8-K
sec.gov
KPTI
Form 8-K
sec.gov
KPTI
Karyopharm Reports First Quarter 2026 Financial Results and Completion of Phase 3 Endometrial Cancer Trial Enrollment
prnewswire.com
KPTI
Karyopharm to Participate at Upcoming Investor Conferences
prnewswire.com
KPTI
Karyopharm's Phase 3 SENTRY Trial in Myelofibrosis Selected for Late-Breaking Oral Presentation at ASCO 2026 Annual Meeting
prnewswire.com
KPTI
Form 8-K
sec.gov
KPTI
Form 8-K
sec.gov
KPTI
Karyopharm Announces $30 Million Private Placement with RA Capital
prnewswire.com
KPTI
Form 8-K
sec.gov
KPTI
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
prnewswire.com
KPTI